Robert E. Hoffman - 01 Jun 2023 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
President, CEO, and CFO, Director
Signature
/s/ Robert E. Hoffman
Issuer symbol
KTRA
Transactions as of
01 Jun 2023
Net transactions value
$0
Form type
4
Filing time
02 Jun 2023, 16:05:29 UTC
Previous filing
03 Aug 2022
Next filing
01 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTRA Common Stock, par value $0.001 per share Award $0 +59,800 +657% $0.000000 68,902 01 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 59,800 restricted stock units, which will be settled in shares of the Issuer's common stock. The restricted stock units vest in full on June 1, 2024.